Patents Assigned to Mor-Research Application Ltd.
  • Patent number: 10531802
    Abstract: A system for vital sign measuring of a patient, comprising: a first sensor removably attachable with a first body portion of the patient and configured to measure, when in operable position, a vital sign of the patient; at least one additional sensor removably attachable with a second body portion of the patient and configured to measure, when in operable position, a vital sign of the patient; and a processor configured to provide data descriptive of a level of correspondence between measurements of the vital signs provided by the first sensor and the at least one additional sensor.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: January 14, 2020
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Nimrod Adi, Gil Zoizner, Jonathan Rubin
  • Publication number: 20190388457
    Abstract: Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly determining the risk of disease relapse following standard treatment. Also described are systems of treatment that are directed by a health care provider, and which include the described prognostic methods and the treatments recommended for patients determined to have a specific relapse risk.
    Type: Application
    Filed: September 11, 2019
    Publication date: December 26, 2019
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Smadar AVIGAD, Isaac YANIV, Keren SHICHRUR
  • Publication number: 20190357774
    Abstract: According to some embodiments there is provided a wearable device for breast screening, comprising: at least one breast-contacting member shaped to contact a surface of a breast, the member comprising an array of force applying units and an array of sensors configured for sensing at least one parameter in response to force applied by the force applying units; the force applying units and the sensors disposed on or within the breast-contacting member and positioned to contact a surface of the breast; a memory storing one or more patterns suitable to detect a lump underlying the surface; wherein the pattern comprises a sequence of forces that vary spatially and/or vary in time; a controller configured for: reading data from the memory to control application of force; communicating with the sensors to receive signals associated with the at least one parameter sensed in response to the application of force; and to process the received signals to detect a lump.
    Type: Application
    Filed: September 9, 2017
    Publication date: November 28, 2019
    Applicant: Mor Research Applications Ltd.
    Inventor: Doron KOPELMAN
  • Patent number: 10441144
    Abstract: A method and system are disclosed for opening a workspace inside a lumen of a living creature are disclosed. Anchors may be affixed to opposite ends of the workspace. An extender may be distance anchors apart while they are affixed to the walls of the workspace. Distancing the anchors may unfold and/or stretch the lumen in the region of the workspace.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 15, 2019
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Igor Igov
  • Publication number: 20190309031
    Abstract: The invention provides isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within said peptides. Pharmaceutical compositions comprising said peptides and antibodies are also disclosed as well as methods of their production and use in vaccination, immunotherapy and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.
    Type: Application
    Filed: June 5, 2019
    Publication date: October 10, 2019
    Applicants: MOR - RESEARCH APPLICATIONS LTD., TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Michal A. Rahat, Nitza Lahat, Miriam Walter, Haim Bitterman
  • Patent number: 10307292
    Abstract: Provided is a device for use in controlling the liquid outflow from the anterior chamber of the eye, methods of draining aqueous humor from the anterior chamber to the intra-orbital space using the device, methods for controlling the liquid outflow from the anterior chamber of the eye and further surgical methods for implanting the presently described device.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: June 4, 2019
    Assignee: MOR RESEARCH APPLICATIONS LTD
    Inventor: Gilad Litvin
  • Patent number: 10300119
    Abstract: Disclosed herein are compositions and methods for treating damage inflicted by use of a cardio-pulmonary bypass (CPB) machine, particularly excessive bleeding and multi organ failure, by administering a pharmaceutical composition comprising alpha-1 antitrypsin (AAT).
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: May 28, 2019
    Assignee: MOR Research Applications Ltd.
    Inventor: Dan Abrahamov
  • Publication number: 20190100731
    Abstract: A method of preparing an ex-vivo intestinal culture model is provided. The method comprising: (a) providing an intestinal tissue sample; (b) treating the intestinal tissue sample with a protease cleaving an extracellular matrix (ECM) component so as to break cell-cell contacts and obtain an intestinal preparation which maintains the overall intestinal tissue structure including villi and/or intestinal tissue layer orientation; (c) washing the preparation; and (d) culturing the preparation.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 4, 2019
    Applicants: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organizat, Mor Research Applications Ltd.
    Inventors: Hinanit KOLTAI, Yoram KAPULNIK, Marcelo FRIDLENDER, Timna NAFTALI
  • Patent number: 10206900
    Abstract: Disclosed herein are methods for treatment for fibrosis, ocular pathologies associated with fibrosis, including proliferative vitreoretinopathy (PVR) by inhibiting the activity of activated transforming growth factor ? activated kinase 1 (TAK1), or activation thereof. Pharmaceutical compositions for use in the described treatments are also provided.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: February 19, 2019
    Assignee: Mor Research Applications Ltd.
    Inventors: Ayala Pollack, Zeev Dvashi
  • Patent number: 10147185
    Abstract: A method for three-dimensional interactive segmentation, including: receiving a three-dimensional medical image of an interior volume of a patient's body; automatically performing three dimensional segmentation on the three dimensional medical image to detect and define a region of interest, wherein the performing of the three dimensional segmentation comprises automatically determining a boundary defining the region of interest; receiving from a user spatial information indicating one or more regions of disagreement in the three-dimensional medical image with respect to the determined boundary; and updating the three dimensional segmentation of the three dimensional medical image based on the spatial information received from the user, wherein the updating comprises updating the determined boundary based on the spatial information to redefine the area of interest.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: December 4, 2018
    Assignees: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY, MOR RESEARCH APPLICATIONS LTD.
    Inventors: Tamar Riklin Raviv, Ilan Shelef, Itzhak Hershkovich, Ohad Chitrit
  • Patent number: 10130682
    Abstract: A method of treating or preventing gonadal or uterine toxicity induced by an agent in a subject is provided. Accordingly there is provided a method comprising administering to a subject a therapeutically effective amount of pigment epithelium-derived factor (PEDF), thereby treating or preventing the gonadal toxicity induced by the agent. Also provided is, a method comprising determining gonadal function in a subject; and administering to the subject a therapeutically effective amount of PEDF, thereby treating or preventing the gonadal toxicity induced by the agent. Also provided is a PEDF for use in the treatment or prevention of gonadal toxicity induced by an agent in a subject. Also provided are cell culture, a medium, a kit and method for improving oocyte quality ex-vivo.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: November 20, 2018
    Assignees: Ramot at Tel-Aviv University Ltd., Mor Research Applications Ltd.
    Inventors: Ruth Shalgi, Dana Chuderland, Hadas Bar-Joseph, Keren Goldberg, Irit Ben-Aharon, Salomon M. Stemmer
  • Patent number: 10058515
    Abstract: The invention provides methods for preventing, ameliorating and treating the acute and chronic forms of graft-versus-host disease (GVHD) by using Cannabidiol compositions.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: August 28, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Moshe Yeshurun
  • Publication number: 20180199937
    Abstract: Provided is a system, a device, a cassette for use therein and method for suturing two tissue sections, for example two sections of a tissue, by using a plurality of consecutively-arranged anchoring units.
    Type: Application
    Filed: July 6, 2016
    Publication date: July 19, 2018
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Eviatar NESHER, Shmuel SEGAL
  • Patent number: 9956182
    Abstract: The invention provides methods for preventing, ameliorating and treating the acute and chronic forms of graft-versus-host disease (GVHD) by using Cannabidiol compositions.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: May 1, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Moshe Yeshurun
  • Patent number: 9943316
    Abstract: According to an aspect of some embodiments of the present invention there is provided a vessel pressure control device configured for selectively applying pressure to a radial artery, the device comprising: a sensor configured to sense one or more parameters associated with blood flow through a portion of the radial artery; a pressure application element adapted to apply variable amounts of pressure to the portion of the radial artery; and a controller configured to apply logic and generate a signal to control the pressure application element in response to the one or more measured parameters, the signal controlling the pressure application element to modify or maintain the applied pressure so that at least some blood flow is maintained through the radial artery portion in an amount sufficient to reduce or prevent radial artery occlusion, and so that the applied pressure is sufficient to prevent bleeding from the portion.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: April 17, 2018
    Assignee: MOR RESEARCH APPLICATION LTD.
    Inventors: Ran Kornowski, Hana Vaknin Assa
  • Patent number: 9921138
    Abstract: A sterile injector comprises a body having a cavity, a hollow needle positionable at a distal end of the injector, a probe holder receivable within the needle, a probe connected to a distal end of the holder, and a driving element axially displaceable within the cavity, for causing relative motion between the probe and the needle upon displacement of the driving element. A sample is injected into a sealed container by displacing the driving element to a first position causing the probe to extend from the needle, applying the extended probe with a sample, displacing the driving element to a second position causing the sample laden probe to be retracted within the needle, piercing a seal of a sealed container with the needle, and displacing the driving element to a third position distally spaced from the first position, after which the probe is injected into the container interior.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: March 20, 2018
    Assignee: Mor Research Applications Ltd.
    Inventors: Amir Hadayer, Noa Hana Hadayer, Arie Leonid Marcovich
  • Patent number: 9907701
    Abstract: A method for repairing a perforation in a tympanic membrane comprising attaching a single patch to an undersurface of the tympanic membrane covering the perforation.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: March 6, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Ariel Margulis
  • Patent number: 9901299
    Abstract: A system for assisted coughing includes a first sensor for measuring a parameter which can indicate a closed glottis and producing a first signal, a processor for receiving the first signal, determining a state indicating the closed glottis and generating an instruction for a Functional Electric Stimulation (FES) controller based, at least in part, on the determining, and a FES controller for generating an electric stimulation signal.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: February 27, 2018
    Assignees: Yeda Research and Development Co. Ltd., Mor Research Applications Ltd.
    Inventors: Lior Haviv, Noam Sobel, Amiram Catz, Itzhak Glass, Anton Plotkin, Aharon Weissbrod, Sagit Shushan
  • Patent number: 9889100
    Abstract: The invention provides methods for preventing, ameliorating and treating the acute and chronic forms of graft-versus-host disease (GVHD) by using Cannabidiol compositions.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: February 13, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Moshe Yeshurun
  • Patent number: 9878021
    Abstract: This disclosure relates to compositions for use in treatment of a retinal degenerative disease, such as age related macular degeneration. The described compositions include agents for activating p38 and/or JNK signaling through the activation of TAK1 in the retinal pigment epithelium of a subject diagnosed with the disease. Methods of treatment of a retinal degenerative disease using the described compositions are also provided.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: January 30, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Ayala Pollack, Zeev Dvashi